Active Ingredient: NYSTATIN
Proprietary Name: NYSTATIN
Dosage Form; Route of Administration: SUSPENSION; ORAL
Strength: 100,000 UNITS/ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A062571
Product Number: 001
Approval Date: Oct 29, 1985
Applicant Holder Full Name: ALPHARMA US PHARMACEUTICALS DIVISION
Marketing Status:
Discontinued
Patent and Exclusivity Information